Portland, OR, April 07, 2021 (GLOBE NEWSWIRE) -- As per the report, the global Digital Therapeutics Market was pegged at $2.88 billion in 2019, and is projected to reach $13.80 billion by 2027, growing at a CAGR of 20.5% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and fluctuating market trends.
Increase in implementation of smartphones and tablets along with healthcare apps, surge in incidences of chronic diseases, and growth in need to control healthcare costs propel the growth of the global digital therapeutics market. On the other hand, lack of awareness regarding digital therapeutics in emerging economies and concerns regarding data privacy restrain the growth to certain extent. Conversely, emerging markets across developing countries are anticipated to usher a number of opportunities in the future.
Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/1674?reqfor=covid
Covid-19 scenario:
- The COVID-19 outbreak has disrupted the global healthcare system. This, in turn, has increased the demand for apps and services for medical intervention and to enhance lifestyle.
- During the period of lockdown, health associations have majorly focused on spreading awareness regarding the significance of digital health.
The global market is segmented on the basis of application, product type, sales channel, and region. Based on application, the diabetes segment dominated the market in 2019, accounting for nearly one-fourth of the global market. In addition, the segment is anticipated to maintain its dominance throughout the forecast period. However, the obesity segment is expected to manifest the highest CAGR of 23.2% during the forecast period. The report also involves segments including cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others
Based on sales channel, the market is bifurcated into business to consumers and business to business. The business to consumers segment accounted for the largest share in 2019, contributing to nearly three-fifths of the total market share. At the same time, the segment is estimated to register the highest CAGR of 21.3% in between 2019 to 2027.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1674
Based on region, the global market across North America held the lion’s share in 2019, accounting for nearly half of the total revenue. The region, furthermore, is anticipated to dominate the market throughout the forecast period. On contrary, the global digital therapeutics market across Asia-Pacific is projected to manifest the highest CAGR of 22.2% during the forecast period.
Major market players in the report involves 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
Nurse Call Systems Market - Global Opportunity Analysis and Industry Forecast, 2020–2026
Intraocular Lens Market - Global Opportunity Analysis and Industry Forecast, 2019-2026
miRNA Tools and Services Market - Global Opportunity Analysis and Industry Forecast, 2019–2026
Healthcare App Market - Global Opportunity Analysis and Industry Forecast, 2019–2026
Multiplex Assays Market - Global Opportunity Analysis and Industry Forecast, 2019–2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.